Efficacy and safety of a novel disposable intravaginal device for treating stress urinary incontinence
- PMID: 18377862
- DOI: 10.1016/j.ajog.2008.01.061
Efficacy and safety of a novel disposable intravaginal device for treating stress urinary incontinence
Abstract
Objective: The purpose of this study was to evaluate the efficacy and safety of a novel disposable intravaginal device for treatment of stress urinary incontinence (SUI) in women.
Study design: Sixty women with severe SUI were recruited from 2 sites in Israel to wear preweighed pads during a 7-day control period followed by a 28-day device usage period in which the device and preweighed pads were worn daily for 8 hours. The primary endpoint was the percentage of women who achieved a > or = 70% reduction in pad weight gain (PWG) from the control period to the last 14 days of device usage.
Results: Sixty women who enrolled into the study and used the device for any period of time were included in the intent to treat (ITT) population. Eighty-five percent of them achieved a > or = 70% reduction in PWG (P = .01). Improvements in overall quality of life, subjective perception of incontinence, and satisfaction with the device were observed.
Conclusion: The intravaginal device is easy to use, well-tolerated, and effective in reducing SUI.
Similar articles
-
Effectiveness of the conveen continence guard (a disposable vaginal device) in the treatment of complicated female stress incontinence.Acta Obstet Gynecol Scand. 2000 Dec;79(12):1052-5. Acta Obstet Gynecol Scand. 2000. PMID: 11130086 Clinical Trial.
-
The adjustable continence therapy system for recurrent female stress urinary incontinence: 1-year results of the North America Clinical Study Group.J Urol. 2009 May;181(5):2187-91. doi: 10.1016/j.juro.2009.01.039. Epub 2009 Mar 17. J Urol. 2009. PMID: 19296967
-
Nonsurgical transurethral collagen denaturation for stress urinary incontinence in women: 12-month results from a prospective long-term study.J Minim Invasive Gynecol. 2009 Jan-Feb;16(1):56-62. doi: 10.1016/j.jmig.2008.09.621. Epub 2008 Nov 13. J Minim Invasive Gynecol. 2009. PMID: 19013110 Clinical Trial.
-
Preventive vaginal and intra-urethral devices in the treatment of female urinary stress incontinence.Curr Opin Obstet Gynecol. 1997 Oct;9(5):325-8. Curr Opin Obstet Gynecol. 1997. PMID: 9360816 Review.
-
Choosing and using disposable body-worn continence pads.Nurs Times. 2005 Jul 19-25;101(29):50-1. Nurs Times. 2005. PMID: 16052946 Review.
Cited by
-
Significant improvement in the quality of life in women treated with a novel disposable intravaginal device for stress urinary incontinence.Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun;20(6):651-8. doi: 10.1007/s00192-009-0824-y. Epub 2009 Mar 11. Int Urogynecol J Pelvic Floor Dysfunct. 2009. PMID: 19434384 Clinical Trial.
-
Efficacy and Tolerance of the Tampsec Vaginal Tampon for Treating Stress Urinary Incontinence. A Randomized Controlled Trial.Int Urogynecol J. 2025 May;36(5):1011-1018. doi: 10.1007/s00192-025-06060-x. Epub 2025 Jan 30. Int Urogynecol J. 2025. PMID: 39883126 Clinical Trial.
-
A Novel Incisionless Disposable Vaginal Device for Female Stress Urinary Incontinence: Efficacy and Quality of Life.Int Neurourol J. 2023 May;27(Suppl 1):S40-48. doi: 10.5213/inj.2346092.046. Epub 2023 May 31. Int Neurourol J. 2023. PMID: 37280759 Free PMC article.
-
Provider Practice Patterns Regarding Over-The-Counter Continence Devices.Int Urogynecol J. 2024 May;35(5):995-1000. doi: 10.1007/s00192-024-05746-y. Epub 2024 Feb 28. Int Urogynecol J. 2024. PMID: 38416152
-
Vaginal microflora following the use of a disposable home-use vaginal device and a commercially available ring pessary for pelvic organ prolapse management: a randomized controlled trial.Arch Gynecol Obstet. 2024 Feb;309(2):571-579. doi: 10.1007/s00404-023-07260-w. Epub 2023 Oct 26. Arch Gynecol Obstet. 2024. PMID: 37882871 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical